Article Text
Editorial commentary
Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis?
Statistics from Altmetric.com
Footnotes
-
Funding MLVDK is supported by a Canadian Institutes of Health Research (CIHR) Doctoral Award – Doctoral Foreign Study Award (October 2012), offered in partnership with the CIHR Strategy for Patient-Oriented Research and the CIHR HIV/AIDS Research Initiative.
-
Competing interests None.
-
Provenance and peer review Commissioned; internally peer reviewed.